SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524742

INE475E01026

242.5445604

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CAPLIPOINT

35.89

13002.56

EPS(TTM)

Face Value()

Div & Yield %

47.66

0.35

Back

Board of MRF recommends interim dividend

Nov 14,2025

MRF announced that the Board of Directors of the Company at its meeting held on 14 November 2025, inter alia, have recommended the interim dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)